process removes cells with damaged DNA from the pool of Among the tests used to determine the mutagenic potential replicating cells, avoiding the introduction of mutations into of chemicals, the chromosomal aberrations and micronuthe genome and the associated risk of cancer (Roberts et al. , cleus assays play an important role. These tests score 1997; Correa and Miller, 1998) . Cell death may be genetically either chromosomal structural aberrations at metaphase controlled and the ability of a cell to survive or die is or micronuclei at interphase. One of the hallmarks of determined by the repertoire of gene products, i.e. p53, apoptosis is DNA fragmentation into 50-300 kpb leading bax, bcl2 and bcl-xL (Denis et al., 1998) . Their differential to oligonucleosomal fragmentation that can interfere with expression is a critical determinant of cell and tissue sensitivity the results of clastogenic assays. In this case, apoptosis may to a toxicant (Roberts et al., 1997) . be a confusing factor in the evaluation of the mutagenic Apoptosis is a form of cell death occurring under physiopotential of molecules and lead to false positive results.
logical conditions or in response to external stimuli, such as For these reasons we have developed a cell line able to DNA-damaging agents, growth factor deprivation or death demonstrate the interference of apoptosis in two mutareceptor triggering (Nagata, 1997; Ashkenazi and Dixit, 1998 ; genicity tests: the in vitro micronucleus test and metaphase Evan and Littlewood, 1998; Green and Reed, 1998) . Apoptosis analysis in vitro. We used a murine cytotoxic T cell line, is characterized by biochemical features including the activa-CTLL-2 Bcl2, in which a stably transfected bcl2 gene is tion of cysteine proteases named caspases, mitochondrial known to protect these cells from apoptosis induced by permeability transition, cell membrane exposure of phosphatidvarious stimuli. A comparison between results obtained in ylserine and DNA cleavage leading to the typical morphology parental CTLL-2 cells and in CTLL-2 Bcl2 cells treated of apoptotic cells, in which the nucleus appears condensed with non-genotoxic apoptosis inducers, such as dexamethaand fragmented. In most cell types DNA cleavage occurs after sone or gliotoxin, leads us to conclude that apoptosis could irreversible activation of endonucleases. An initial cleavage of give false positive results due to DNA fragmentation.
DNA into 50-300 kpb induces chromatin condensation and in Moreover, with etoposide, a clastogen that also induces most cell types oligonucleosomal fragmentation follows due apoptosis, we observed that the percentages of aberrant to double-stranded cleavage of DNA in the linker region of cells and numbers of micronuclei were significantly nucleosomes (Saraste and Pulkki, 2000) .
increased in CTLL-2 cells compared with CTLL-2 Bcl2
During the process of apoptosis and at the stage of chromatin cells. This observation suggests that apoptosis leads to an condensation the original nucleus splits into a number of overestimation of the genotoxic potential of chemicals.
dense micronuclei, scattered throughout the cytoplasm (Di Finally, with nocodazole, an aneugen, we confirm that this Baldassarre et al., 2000) . These micronuclei generally appear model can also detect agents that have only genotoxic surrounded by a double membrane system, externally outlined potential and thus allows a better estimation of the genoby ribosomes. The functional role of these micronuclei is toxic threshold in studies with aneugens, thus avoiding still unknown, but it is generally accepted that they contain overestimation of the mutagenic risk of such a compound.
sequestered inactive genetic material (Columbaro et al., 1998) . Consequently, in the in vitro micronucleus test a possible problem is that the very early steps of chromatin condensation Introduction due to apoptosis are not easily distinguishable from micronuclei induced by chemicals using Giemsa staining. Moreover, Simkó The development of new chemicals requires investigation of et al. (1998) showed in human cell lines that the increase in their mutagenic potential. Several tests are now routinely apoptotic cells is positively correlated with the appearance of performed and are required for mutagenic risk assessment micronuclei. Poma et al. (1999) have observed that proliferating before approval by various regulatory agencies. These include lymphocytes undergoing apoptosis after saporin treatment the Ames assay, the in vitro gene mutation assay in eukaryotic showed DNA damage during the first metaphase, after which cells, the in vitro chromosome aberration assay and the in vivo the cells die and no metaphases are observable. micronucleus test (ICH, 1997) .
A number of genes have been discovered that are involved The process of repairing damaged DNA is of primary importance since DNA damage can be converted into mutations in apoptosis, such as those belonging to the bcl2 family. The (Selvakumaran, 1994; Kitada et al., 1996) .
The properties of Bcl2 were utilized in two murine lymphoChalfont, UK).
cyte cell lines: CTLL-2 and CTLL-2 Bcl2. In the latter the majority and prevent the cells from becoming apoptotic.
The cells were centrifuged for 5 min at 200 g and fixed with 10 ml of Carnoy II fixative mixture (3 vol. ethanol, 1 vol. acetic acid) for 10 min. After
In this work we have studied the occurrence of apoptosis another centrifugation the cells were spread on slides and stained with Giemsa as a confounding factor in the evaluation of the genotoxic dye (Sigma) diluted at 5% in water. Micronucleated cells were analysed in at potential of xenobiotics. We used the in vitro micronucleus least 1000 cells/culture of three parallel cultures (3000 cells/dose) at 500ϫ test and in vitro metaphase analysis, which both detect early magnification. The criteria for micronucleus determination are that the intensity of stained micronuclei is inferior to the principal nucleus, its diameter is genotoxic events, in parallel with two apoptosis detection inferior to the principal nucleus, it is round with a nuclear membrane, it is methods, YOPRO-1 labelling (Idziorek et al., 1995) , which not connected to the principal nucleus, there is no overlap with the principal stains apoptotic cells and is fluorescent only after intercalation nucleus and it is within the cytoplasm.
between base pairs, and Annexin V staining, which measures
In vitro metaphase analysis test phosphatidylserine residue expression during the early stages CTLL-2 or CTLL-2 Bcl2 cells (75 000 cells/ml), cultured in complete RPMI of apoptosis (Andree et al., 1990) . This approach was conducted medium containing 25 pg/ml IL-2, were treated for 15 h with the compounds at different concentrations. Two hours prior to harvesting 0.1 µg/ml colcemid in the two cell lines described, thus allowing us to demonstrate (Fluka/Sigma-Aldrich Chemical Co.) was added. Cells were harvested after interference by apoptosis in mutagenicity tests. 
Materials and methods
acetic acid) for 12 min. After a further centrifugation the cells were spread on slides and stained for 10 min with Giemsa dye diluted at 4% in water. At Cell lines and culture conditions least 100 cells/culture (100 cells/dose) were screened for aberrant cells at CTLL-2 is a subclone of cytotoxic T lymphocytes from mouse strain C57bl/ 1000ϫ magnification, scoring chromosome and chromatid-type aberrations. 6. The cells were routinely cultured in complete RPMI 1640 medium (Gibco Apoptosis detection BRL, Paisley, UK) containing 10% foetal calf serum (FCS) (Gibco BRL) heat-inactivated for 30 min at 56°C, 20 mg/ml sodium pyruvate (Sigma-
Cells were washed in culture medium and resuspended in HEPES buffer (Gibco BRL), 2 mM HEPES (Sigma), 100 UI/ml penicillin (Gibco BRL), 0.1 (10 mM HEPES, pH 7.4, 140 mM NaCl, 5 mM KCl, 5 mM CaCl 2 )/NaOH at mg/ml streptomycin (Gibco BRL) and 5ϫ10 -5 M β-mercaptoethanol (Merck, a concentration of 10 6 cells/ml. Cells were stained with Annexin V-FITC Nogent-sur-Marne, France) supplemented with 1 ng/ml interleukin-2 (IL-2) (10 µg/ml final concentration) and propidium iodide (0.5 µg/ml final concentra-(Chiron, France). tion) for 15 min in the dark at room temperature. Fluorescence of at least The CTLL-2 Bcl2 cell line was produced by stable transfection of CTLL-2 10 000 cells was then assessed using bivariate flow cytometry (Epics II; with the pSFFV neo Bcl2 plasmid (a kind gift of Dr S.Korsmeyer) containing Coulter, Margency, France) and the percentages of viable, apoptotic and a 1. et al., 2000) . Briefly, CTLL-2 cells were electroporated with 10 µg plasmid cells no longer viable). Annexin V staining was performed in parallel with using a Bio-Rad gene pulser set at 250 V and 960 µF. CTLL-2 Bcl2 cells mutagenicity assays. The percentages of FITC ϩ /IP -cells, corresponding to were selected in complete medium containing 800 µg/ml G418 (Gibco) for cells in the early stage of apoptosis, are those used in the studies of each compound. 2 weeks and cloned by limiting dilution. Expression of Blc2 (reaching 90.2%) was measured by intracellular staining using anti-human Bcl2 (Dako, France)
YOPRO-1 method labelled with FITC and flow cytometry. Both cell lines were cultured in a Cells were washed in RPMI 1640 medium and YOPRO-1 (10 µM) was added humidified incubator containing 5% CO 2 at 37°C.
(1 µl/10 6 cells/ml) to the cells for 10 min (20) . Fluorescence of at least 10 000 cells was then assessed using bivariate flow cytometry (Epics II) and the Compounds percentage of apoptotic cells (YOPRO-1 ϩ cells) was measured. YOPRO-1 Dexamethasone, gliotoxin, etoposide and nocodazole were purchased from staining was performed in parallel with mutagenicity assays. Sigma (Sigma-Aldrich Chemical Co.); methane methylsulphonate (MMS) was DNA extraction and gel electrophoresis analysis purchased from Aldrich. The test compounds were dissolved in DMSO (final concentration not exceeding 0.2%) and stored at -20°C. The first two Treated cells were washed in PBS and incubated for 30 min at 4°C in lysis compounds are not carcinogens in humans whereas the others are possible buffer (5 mM Tris, 20 mM EDTA, 0.5% Triton X-100; all from Sigma). The carcinogens (class 2B in the IARC classification).
DNA from the cell lysate was precipitated with 1/10 vol. 3 M sodium acetate These compounds were studied up to concentrations inducing apoptosis and 2 vol. cold absolute ethanol for 1 h at -80°C. The DNA was then and/or cytotoxicity (measured by Trypan Blue exclusion) in Ͼ50% of the incubated for 5 h at 37°C with RNase (500 µg/ml; Boehringer Mannheim) and extraction buffer (10 mM Tris, 5 mM EDTA). DNA was then incubated cells according to OECD guidelines (OECD, 1997). overnight at 65°C with proteinase K (1.25 mg/ml), 10ϫ proteinase K buffer (100 mM Tris, 100 mM EDTA, 250 mM NaCl) and extraction buffer. The proteins were extracted with water-saturated phenol. The aqueous phase was harvested and phenol was eliminated with chloroform:isoamyl alcohol (24:1). fragmentation was present when CTLL-2 Bcl2 cells were treated with dexamethasone, demonstrating that overexpression of Bcl2 in CTLL-2 cells protects them from apoptosis Results (Figure 2 ).
Expression of p53 in CTLL-2 and CTLL-2 Bcl2 cells
Evaluation with compounds inducing apoptosis in CTLL-2 Apoptosis can occur by a p53-dependent pathway as well as cells by a p53-independent pathway (Vogt Sionov and Haupt, 1999) . Therefore, it is important to verify that CTLL-2 cells express To assess whether apoptosis can lead to chromosome and chromatid breakage we compared the results obtained in this protein.
Genotoxins are known to induce p53 expression in order to parental CTLL-2 cells with those obtained in CTLL-2 cells stably transfected with the apoptosis inhibitor gene bcl2 and control the cell cycle (Yang and Duerksen-Hugues, 1998) . CTLL-2 and CTLL-2 Bcl2 cells were treated with 10 and 100 treated with either dexamethasone or gliotoxin, which are apoptotic but not genotoxic compounds. Two tests were used: µM MMS, an alkylating agent known to induce p53 expression (Zhan et al., 1993) , and were examined by western blotting the in vitro micronucleus test and metaphase analysis. Apoptosis was evaluated with Annexin V and YOPRO-1 for expression of p53 and its induction by genotoxic stress.
The results showed that wild-type p53 is normally present staining, which quantify two different outcomes of apoptosis.
In the in vitro micronucleus test we observed a dosein the two cell lines without genotoxic treatment and its dependent increase in the number of micronucleated cells in action of glucocorticoids. Chromosome and chromatid breaks, but never chromatid exchanges, were observed following CTLL-2 cells treated with dexamethasone, with maxima of 38.3 and 39.6‰ at 75 and 150 nM, respectively. This increase dexamethasone treatment (Tables I and II) . However, when CTLL-2 Bcl2 cells were treated with dexamethasone we did was statistically significant at doses of 18.75 nM and higher (Figure 2A) . Similar results were obtained in the in vitro not observe an increase in micronucleated cells or aberrant cells at any of the doses tested (Figure 2A and B) . metaphase analysis, where dexamethasone significantly increased the percentage of aberrant cells at doses of 37.5 nM Gliotoxin, another apoptosis inducer, was studied at a range of doses from 25 to 200 nM (Figure 3 ). In the in vitro and higher ( Figure 2B ). The percentage of aberrant cells was reduced at the highest dose of dexamethasone used (150 nM).
micronucleus test gliotoxin was positive at 100 and 200 nM in CTLL-2 cells (P Ͻ 0.01, Figure 3A ) whereas in the This effect could be the consequence of the anti-proliferative to 500 nM, induced a dose-dependent increase of the number metaphase analysis test a statistically significant difference of micronucleated cells in both CTLL-2 and CTLL-2 Bcl2 was present at Ͼ50 nM ( Figure 3B ). Concentrations in the cells ( Figure 4A ). This effect was also observed in the metaphase analysis assay were not tested over 50 nM in metaphase analysis test, with a dose-dependent increase in the CTLL-2 cells due to the absence of mitosis. Apoptosis was percentage of aberrant cells in both cell lines. This increase present at 100 and 200 nM using either Annexin V-FITC was statistically significant from 62.5 nM in CTLL-2 cells and staining or the YOPRO-1 assay ( Figure 3C and D) . Again, from 125 nM in CTLL-2 Bcl2 cells ( Figure 4B and Tables I when CTLL-2 Bcl2 cells were treated with gliotoxin neither and II). Apoptosis was present in CTLL-2 cells treated with micronuclei, aberrant cells nor apoptosis were present at etoposide, with 29% apoptotic cells at the higher dose, but not a significantly higher level compared with control cells at in CTLL-2 Bcl2 cells, suggesting that etoposide provoked concentrations up to 200 nM ( Figure 3A-D) .
genotoxicity independently of apoptosis. However, the numbers These studies using compounds known to induce apoptosis of micronucleated cells and the percentages of aberrant cells but devoid of genotoxicity demonstrated: (i) micronucleated were always significantly higher in parental CTLL-2 cells cells or aberrant cell number did not increase following compared with CTLL-2 Bcl2 cells. This difference is probably treatment with either dexamethasone or gliotoxin in CTLL-2 the consequence of DNA fragmentation during apoptosis that Bcl2 cells whereas they did increase in parental CTLL-2 cells; occurs in parental CTLL-2 cells leading to higher numbers in (ii) the presence of micronucleated cells or aberrant cells was both tests compared with CTLL-2 Bcl2 cells. correlated with the occurrence of apoptosis.
It is interesting to note that with the non-genotoxic apoptosis Evaluation with compounds inducing both genotoxicity and inducers (dexamethasone and gliotoxin) chromosome breaks apoptosis in CTLL-2 cells but no exchanges were observed (Tables I and II) . In contrast, with etoposide chromosome breaks and exchanges were observWe compared the results obtained in the two murine cell lines with compounds that are both genotoxic and apoptotic to test able. On the one hand, this difference arises from the difference in primary DNA damage. On the other hand, this difference whether apoptosis could lead to an overestimation of the genotoxic potential of chemicals using mutagenicity tests.
is due to the fact that in apoptotic cells no DNA repair occurred while in cells with primary DNA damage repair occurred Etoposide, studied in a range of concentrations from 62.5 ously mentioned by several authors without clear discrimination between the two phenomena (clastogenesis and apoptosis): Singh et al. (1994) concluded that dexamethasone induced a positive response in metaphase analysis in vitro in human lymphocytes when a long incubation time was used.
Moreover, in an investigation of the mechanism of induction of nuclear anomalies, Guo et al. (1998) observed that γ-irradiation led to a low number of micronucleated cells correlated with a low apoptotic cell frequency. Thus they proposed that γ-radiation, an apoptosis inducing agent and also a true clastogen, induced both processes and indistinguishable micronuclei. In contrast, Kirsch-Volders et al. (1997) showed, in a study of the in vitro micronucleus test, that cells suffering injury by chemicals, especially genotoxins, could undergo apoptosis. In that case, depending on the degree of chromatin condensation, round shaped vesicles containing chromatin fragments could be observed in the cytoplasm as micronuclei. They stressed the fact that the frequency of micronucleated cells included apoptotic cells. In the same way, Ronen and Heddle (1984) , studying nuclear damage after treatment of mice with carcinogens, noticed that among the anomalies some appeared as micronuclei or apoptotic nuclei, but sometimes micronuclei were indistinguishable from apoptotic nuclei, leading to the conclusion of both of the two sorts of anomalies and thus false results.
For these reasons it is necessary to distinguish DNA fragmentation due to apoptosis from that due to a true genotoxic effect in mutagenicity tests in order to have a better understanding of the chromosomal aberrations observed. This differentiation is difficult to perform in the case of apoptosis induction hormones. During this work we compared the results obtained in the CTLL-2 parental cell line with that obtained in CTLL-2 cells transfected with the bcl2 gene. leading to chromosome exchanges. In practice, a high level of CTLL-2 cells are able to respond to genotoxic stress, as breaks without exchanges induced by a test compound could shown by p53 induction following MMS treatment. Moreover, alert one to suspect a role of apoptosis in breakage induction.
The aneugenic molecule nocodazole, studied over a range these cells show oligonucleosomal DNA fragmentation during of doses from 40 to 100 nM, was also able to induce both an the process of apoptosis. increase in the number of micronucleated cells (354/1000 at We first addressed the question whether DNA fragmentation the higher concentration) and in the percentage of apoptotic occurring during apoptosis could give false positive results in cells (22% at the highest concentration) in parental CTLL-2 mutagenicity assays such as the in vitro micronucleus test and cells ( Figure 5 ). In CTLL-2 Bcl2 cells nocodazole did not in vitro metaphase analysis. These two tests permit the detection induce apoptosis but significantly increased in a doseof primary DNA damage due to a clastogenic treatment. dependent manner the number of micronucleated cells ( Figure  Two non-genotoxic molecules that are well-known apoptosis 5A), leading to a statistically significant difference in the inducers were studied, dexamethasone and gliotoxin. number of aberrant cells between the two cell lines. No Dexamethasone, a synthetic glucocorticoid, is a well-known metaphase analyses were conducted since the OECD guidelines apoptosis inducer in lymphoid cell lines (Perrin-Wolff et al., (OECD, 1997) note that this assay is not pertinent to the study 1995; McColl et al., 1998) . CTLL-2 cells respond to glucoof aneugenic compounds. Again, like etoposide, the number corticoid treatment and become apoptotic (Perrin-Wolff et al., of micronucleated cells was higher in parental cells compared 1996). Gliotoxin, a fungal toxin, has suppressive effects, with CTLL-2 Bcl2 cells, suggesting that apoptosis participates inhibiting NFκB, and induces apoptosis through elevation of in the production of micronucleated cells in the parental the cAMP level. Then protein kinase A activation (Sutton CTLL-2 line ( Figure 5A) . et al., 1995) leads to hyperphosphorylation of histone H3 on serine residues to make them more sensitive to nucleases Discussion (Waring et al., 1997) and apoptosis takes place. The induction of apoptosis by dexamethasone or gliotoxin treatment was The overestimation of chromosomal aberrations due to interference of apoptotic DNA fragmentation is a problem previresponsible for misinterpretation of the results, since it led us to conclude a genotoxic effect for the compounds, which References constituted false positive responses.
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